A citation-based method for searching scientific literature

Milos D Ikonomovic, Chris J Buckley, Kerstin Heurling, Paul Sherwin, Paul A Jones, Michelle Zanette, Chester A Mathis, William E Klunk, Aruna Chakrabarty, James Ironside, Azzam Ismail, Colin Smith, Dietmar R Thal, Thomas G Beach, Gill Farrar, Adrian P L Smith. Acta Neuropathol Commun 2016
Times Cited: 60







List of co-cited articles
591 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Phases of A beta-deposition in the human brain and its relevance for the development of AD.
Dietmar R Thal, Udo Rüb, Mario Orantes, Heiko Braak. Neurology 2002
50

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.
Christopher M Clark, Michael J Pontecorvo, Thomas G Beach, Barry J Bedell, R Edward Coleman, P Murali Doraiswamy, Adam S Fleisher, Eric M Reiman, Marwan N Sabbagh, Carl H Sadowsky,[...]. Lancet Neurol 2012
519
43


Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.
Osama Sabri, Marwan N Sabbagh, John Seibyl, Henryk Barthel, Hiroyasu Akatsu, Yasuomi Ouchi, Kohei Senda, Shigeo Murayama, Kenji Ishii, Masaki Takao,[...]. Alzheimers Dement 2015
282
36

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
31

Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.
Craig Curtis, Jose E Gamez, Upinder Singh, Carl H Sadowsky, Teresa Villena, Marwan N Sabbagh, Thomas G Beach, Ranjan Duara, Adam S Fleisher, Kirk A Frey,[...]. JAMA Neurol 2015
174
31

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.
S S Mirra, A Heyman, D McKeel, S M Sumi, B J Crain, L M Brownlee, F S Vogel, J P Hughes, G van Belle, L Berg. Neurology 1991
30

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E Klunk, Henry Engler, Agneta Nordberg, Yanming Wang, Gunnar Blomqvist, Daniel P Holt, Mats Bergström, Irina Savitcheva, Guo-feng Huang, Sergio Estrada,[...]. Ann Neurol 2004
28

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
28

[(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology.
Dietmar Rudolf Thal, Thomas G Beach, Michelle Zanette, Kerstin Heurling, Aruna Chakrabarty, Azzam Ismail, Adrian P L Smith, Christopher Buckley. Alzheimers Dement 2015
90
26

In vivo staging of regional amyloid deposition.
Michel J Grothe, Henryk Barthel, Jorge Sepulcre, Martin Dyrba, Osama Sabri, Stefan J Teipel. Neurology 2017
195
26

Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.
Thomas G Beach, Dietmar Rudolf Thal, Michelle Zanette, Adrian Smith, Christopher Buckley. J Alzheimers Dis 2016
34
44

The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
William E Klunk, Robert A Koeppe, Julie C Price, Tammie L Benzinger, Michael D Devous, William J Jagust, Keith A Johnson, Chester A Mathis, Davneet Minhas, Michael J Pontecorvo,[...]. Alzheimers Dement 2015
362
25

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Victor L Villemagne, Samantha Burnham, Pierrick Bourgeat, Belinda Brown, Kathryn A Ellis, Olivier Salvado, Cassandra Szoeke, S Lance Macaulay, Ralph Martins, Paul Maruff,[...]. Lancet Neurol 2013
25

Use of florbetapir-PET for imaging beta-amyloid pathology.
Christopher M Clark, Julie A Schneider, Barry J Bedell, Thomas G Beach, Warren B Bilker, Mark A Mintun, Michael J Pontecorvo, Franz Hefti, Alan P Carpenter, Matthew L Flitter,[...]. JAMA 2011
728
25

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
Milos D Ikonomovic, William E Klunk, Eric E Abrahamson, Chester A Mathis, Julie C Price, Nicholas D Tsopelas, Brian J Lopresti, Scott Ziolko, Wenzhu Bi, William R Paljug,[...]. Brain 2008
662
25

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.
Bradley T Hyman, Creighton H Phelps, Thomas G Beach, Eileen H Bigio, Nigel J Cairns, Maria C Carrillo, Dennis W Dickson, Charles Duyckaerts, Matthew P Frosch, Eliezer Masliah,[...]. Alzheimers Dement 2012
23

Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease.
Stephen Salloway, Jose E Gamez, Upinder Singh, Carl H Sadowsky, Teresa Villena, Marwan N Sabbagh, Thomas G Beach, Ranjan Duara, Adam S Fleisher, Kirk A Frey,[...]. Alzheimers Dement (Amst) 2017
46
30

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
Rik Vandenberghe, Koen Van Laere, Adrian Ivanoiu, Eric Salmon, Christine Bastin, Eric Triau, Steen Hasselbalch, Ian Law, Allan Andersen, Alex Korner,[...]. Ann Neurol 2010
460
20

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
18

Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
Melissa E Murray, Val J Lowe, Neill R Graff-Radford, Amanda M Liesinger, Ashley Cannon, Scott A Przybelski, Bhupendra Rawal, Joseph E Parisi, Ronald C Petersen, Kejal Kantarci,[...]. Brain 2015
210
18

PET staging of amyloidosis using striatum.
Bernard J Hanseeuw, Rebecca A Betensky, Elizabeth C Mormino, Aaron P Schultz, Jorge Sepulcre, John A Becker, Heidi I L Jacobs, Rachel F Buckley, Molly R LaPoint, Patrizia Vannini,[...]. Alzheimers Dement 2018
64
18

Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition.
Dietmar Rudolf Thal, Thomas G Beach, Michelle Zanette, Johan Lilja, Kerstin Heurling, Aruna Chakrabarty, Azzam Ismail, Gill Farrar, Christopher Buckley, Adrian P L Smith. Acta Neuropathol 2018
27
40

Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol β-amyloid PET brain images.
Christopher J Buckley, Paul F Sherwin, Adrian P L Smith, Jan Wolber, Sharon M Weick, David J Brooks. Nucl Med Commun 2017
43
23

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.
William E Klunk, Julie C Price, Chester A Mathis, Nicholas D Tsopelas, Brian J Lopresti, Scott K Ziolko, Wenzhu Bi, Jessica A Hoge, Ann D Cohen, Milos D Ikonomovic,[...]. J Neurosci 2007
303
16

Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology.
Renaud La Joie, Nagehan Ayakta, William W Seeley, Ewa Borys, Adam L Boxer, Charles DeCarli, Vincent Doré, Lea T Grinberg, Eric Huang, Ji-Hye Hwang,[...]. Alzheimers Dement 2019
76
16

Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Elizabeth Morris, Anastasia Chalkidou, Alexander Hammers, Janet Peacock, Jennifer Summers, Stephen Keevil. Eur J Nucl Med Mol Imaging 2016
116
15

The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
15

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.
Thomas J Montine, Creighton H Phelps, Thomas G Beach, Eileen H Bigio, Nigel J Cairns, Dennis W Dickson, Charles Duyckaerts, Matthew P Frosch, Eliezer Masliah, Suzanne S Mirra,[...]. Acta Neuropathol 2012
15

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques.
Milos D Ikonomovic, Enrico R Fantoni, Gill Farrar, Stephen Salloway. Alzheimers Res Ther 2018
16
56

Classification of primary progressive aphasia and its variants.
M L Gorno-Tempini, A E Hillis, S Weintraub, A Kertesz, M Mendez, S F Cappa, J M Ogar, J D Rohrer, S Black, B F Boeve,[...]. Neurology 2011
13

Primary age-related tauopathy (PART): a common pathology associated with human aging.
John F Crary, John Q Trojanowski, Julie A Schneider, Jose F Abisambra, Erin L Abner, Irina Alafuzoff, Steven E Arnold, Johannes Attems, Thomas G Beach, Eileen H Bigio,[...]. Acta Neuropathol 2014
762
13



Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
Sylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, Cindee Madison, Nagehan Ayakta, Pia M Ghosh, Renaud La Joie, Samia Kate Arthur-Bentil, Jacob W Vogel, Shawn M Marks,[...]. Brain 2015
229
11

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
Rik Ossenkoppele, Daniel R Schonhaut, Michael Schöll, Samuel N Lockhart, Nagehan Ayakta, Suzanne L Baker, James P O'Neil, Mustafa Janabi, Andreas Lazaris, Averill Cantwell,[...]. Brain 2016
564
11

PET Imaging of Tau Deposition in the Aging Human Brain.
Michael Schöll, Samuel N Lockhart, Daniel R Schonhaut, James P O'Neil, Mustafa Janabi, Rik Ossenkoppele, Suzanne L Baker, Jacob W Vogel, Jamie Faria, Henry D Schwimmer,[...]. Neuron 2016
603
11

Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.
Susan M Landau, Allison Fero, Suzanne L Baker, Robert Koeppe, Mark Mintun, Kewei Chen, Eric M Reiman, William J Jagust. J Nucl Med 2015
184
11

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
Marta Marquié, Marc D Normandin, Charles R Vanderburg, Isabel M Costantino, Elizabeth A Bien, Lisa G Rycyna, William E Klunk, Chester A Mathis, Milos D Ikonomovic, Manik L Debnath,[...]. Ann Neurol 2015
429
11

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
Oskar Hansson, John Seibyl, Erik Stomrud, Henrik Zetterberg, John Q Trojanowski, Tobias Bittner, Valeria Lifke, Veronika Corradini, Udo Eichenlaub, Richard Batrla,[...]. Alzheimers Dement 2018
257
11

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).
Dean F Wong, Paul B Rosenberg, Yun Zhou, Anil Kumar, Vanessa Raymont, Hayden T Ravert, Robert F Dannals, Ayon Nandi, James R Brasić, Weiguo Ye,[...]. J Nucl Med 2010
474
11

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
Henryk Barthel, Hermann-Josef Gertz, Stefan Dresel, Oliver Peters, Peter Bartenstein, Katharina Buerger, Florian Hiemeyer, Sabine M Wittemer-Rump, John Seibyl, Cornelia Reininger,[...]. Lancet Neurol 2011
371
10

Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
Lennart Thurfjell, Johan Lilja, Roger Lundqvist, Chris Buckley, Adrian Smith, Rik Vandenberghe, Paul Sherwin. J Nucl Med 2014
122
10

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
10

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling,[...]. Nature 2016
10

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Willemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, Betty M Tijms, Philip Scheltens, Frans R J Verhey, Pieter Jelle Visser, Pauline Aalten, Dag Aarsland, Daniel Alcolea,[...]. JAMA 2015
844
10

An autoradiographic evaluation of AV-1451 Tau PET in dementia.
Val J Lowe, Geoffry Curran, Ping Fang, Amanda M Liesinger, Keith A Josephs, Joseph E Parisi, Kejal Kantarci, Bradley F Boeve, Mukesh K Pandey, Tyler Bruinsma,[...]. Acta Neuropathol Commun 2016
299
10


Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.
Sebastian Palmqvist, Michael Schöll, Olof Strandberg, Niklas Mattsson, Erik Stomrud, Henrik Zetterberg, Kaj Blennow, Susan Landau, William Jagust, Oskar Hansson. Nat Commun 2017
351
10

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.
Hanna Cho, Jae Yong Choi, Mi Song Hwang, You Jin Kim, Hye Mi Lee, Hye Sun Lee, Jae Hoon Lee, Young Hoon Ryu, Myung Sik Lee, Chul Hyoung Lyoo. Ann Neurol 2016
263
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.